Meyer Handelman CO Organon & Co. Transaction History

Meyer Handelman CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$30.45 - $39.36 $268,538 - $347,115	-8,819 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$28.67 - $37.13 $176,865 - $229,054	-6,169 Reduced 41.16%	8,819 $269,000
Q3 2021 Nov 01, 2021	SELL	$28.63 - $35.64 $579,929 - $721,923	-20,256 Reduced 57.47%	14,988 $491,000
Q2 2021 Aug 18, 2021	BUY	$28.45 - $38.0 $1 Million - $1.34 Million	35,244 New	35,244 $1.07 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

Stay updated on Meyer Handelman CO with notifications on news.